BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11769082)

  • 1. [Pathologic anatomy of superficial tumors of the bladder].
    Billerey C; Sibony M; Gattegno B; Chopin D
    Prog Urol; 2001 Nov; 11(5):805-63. PubMed ID: 11769082
    [No Abstract]   [Full Text] [Related]  

  • 2. [So-called "superficial" bladder tumors. Which classification in 2003? Part 1: Papillary tumors].
    Billerey C; Sibony M
    Ann Pathol; 2003 Feb; 23(1):21-33. PubMed ID: 12743497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging and terminology of superficial urinary bladder tumors.
    Cannon SB
    J Insur Med; 2001; 33(4):360-2. PubMed ID: 11877919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors.
    Yan Y; Andriole GL; Humphrey PA; Kibel AS
    Cancer; 2002 Sep; 95(6):1239-46. PubMed ID: 12216091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
    Sibony M; Billerey C
    Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology and staging of bladder cancer.
    Bane BL; Rao JY; Hemstreet GP
    Semin Oncol; 1996 Oct; 23(5):546-70. PubMed ID: 8893867
    [No Abstract]   [Full Text] [Related]  

  • 7. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, staging, and classification of bladder tumors.
    Cummings KB
    Semin Urol; 1983 Feb; 1(1):7-14. PubMed ID: 6679097
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD138-positive plasmacytoid urothelial carcinoma of the bladder.
    Patriarca C; Di Pasquale M; Giunta P; Bergamaschi F
    Int J Surg Pathol; 2008 Apr; 16(2):215-7. PubMed ID: 18417684
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
    Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
    J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumors of the bladder. Pathological anatomy].
    Vieillefond A; Carbillet JP
    Rev Prat; 1993 Sep; 43(13):1709-11. PubMed ID: 8303194
    [No Abstract]   [Full Text] [Related]  

  • 15. [New information in the classification of urothelial tumors of the bladder].
    Guillou L
    Ann Pathol; 1999; 19(5 Suppl):S103-7. PubMed ID: 10599468
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients with superficial transitional cell carcinoma of the bladder and their smoking status.
    Smith JA
    Cancer; 1999 Dec; 86(11):2192-4. PubMed ID: 10590355
    [No Abstract]   [Full Text] [Related]  

  • 18. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.
    Boorjian S; Ugras S; Mongan NP; Gudas LJ; You X; Tickoo SK; Scherr DS
    Urology; 2004 Aug; 64(2):383-8. PubMed ID: 15302512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomorphology of urothelial carcinomatous peritoneal effusion.
    Xiao GQ
    Cytopathology; 2008 Apr; 19(2):131-3. PubMed ID: 18241206
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.